RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:Get ready for more merger mania in the pharma sector With all due respect, Notable, I'm not following your logic. To my mind, having 12 years' marketing exclusivity is the very definition of timebound. However, each separate combo of pela with another agent would start a separate 12-year exclusivity period; is this what you mean? In that sense it is similar to a mining company discovering a new ore body (which they all try to do to extend mine life and/or throughput).
In any case, I'm not worried. Even if Pela had only one combo (with, say, Bavencio) for twelve years, that would likely be enough to justify the $8 to $15 billion valuation being bandied about. The rest is just icing on the cake for the BP.